This Award Notice opportunity from Department Of Defense was posted on August 31, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

NALOXONE HYDROCHLORIDE INJECTION

Awarded

SPE2DP26F9366Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412

New

DIBBS

Sterile Surgical Lubricant Supplier

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Varicella Virus Vaccine Manufacturer

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Sterile Sodium Chloride and Hypodermic Needle Supplier

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Supply of Magnesium Sulfate Oral Granules

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supplier of Isopropyl Alcohol USP (99%)

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Isoniazid Tablets (USP 300 MG)

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

CHLORINE TEST REAGENT

Solicitation # SPE2DS-27-T-1528

Solicitation SPE2DS-27-T-1528, issued by the Defense Logistics Agency, is for the procurement of DPD Total Chlorine Reagent under NSN 6550-01-460-7597. The requirement consists of powder pillows with a 10 ML sample size, issued in packages of 100 units each. The total quantity requested is 101 packages, with delivery required within 20 days. Delivery is FOB Destination, with shipments directed to the USS Santa Barbara LCS 32 and the USS Hopper DDG 70. The reagents must have a non-extendable shelf life of 60 months, and no more than 8 months may have elapsed from the date of manufacture to the date of government delivery. Packaging must be commercial and sealed to prevent damage, adhering to Medical Marking Standard No. 1 and MIL-STD-129. Hazardous materials must be labeled according to the Hazard Communication Standard and packaged per TQ requirement IP025. All payment requests and receiving reports must be processed electronically through the Wide Area WorkFlow system. The contract incorporates various FAR and DFARS clauses, including requirements for safeguarding covered defense information and compliance with the Buy American Act.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Solicitation # SPE2DP-27-T-0256

Solicitation SPE2DP-27-T-0256, issued by the DLA Troop Support Medical Supply Chain Pharm FSA, is a small business set-aside for the procurement of Isopropyl Alcohol USP (rubbing alcohol). The required product must have a concentration of 99% Isopropanol and be issued in bottles containing 473 milliliters, 1 pint, or 16 ounces. The contract specifies a delivery period of 20 days after receipt of order, with the place of performance located in FPO, ZIP 96692, and terms set as FOB Destination. Inspection and acceptance will occur at the destination per FAR 52.246-2. Due to the highly flammable nature of the material, the contract mandates strict hazardous materials compliance. This includes providing a current Material Safety Data Sheet (MSDS) via the DLA electronic mailbox and accompanying every shipment. Packaging must adhere to TQ requirement IP025, MIL-STD-129, and DLAI 4145.3 for military aircraft shipments, while labeling must comply with 49 CFR, 29 CFR, and Medical Marking Standard No. 1. The contractor must provide a signed certification of package configuration on the DD Form 250 and maintain packaging test reports for three years. Administrative requirements include the use of the Wide Area WorkFlow (WAWF) system for invoicing and adherence to the Buy American Act and NIST SP 800-171 cybersecurity standards.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

RABIES VACCINE, VETERIN

Solicitation # SPE2DP-27-T-0253

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-27-T-0255

This contract, issued by the DLA Troop Support Medical Supply Chain Pharm FSA, is a small business set-aside for the procurement of Isoniazid Tablets (NSN 6505-00-132-6904). The requirement is for two bottles of USP 300 MG tablets in quantities of 100 per bottle, which must be stored at medical controlled room temperature. The items have a non-extendable shelf life of 36 months and are regulated by the FDA. Delivery is specified as FOB Destination to the USS Stockdale DDG 106, with a required delivery timeframe of 20 days. The contract mandates strict adherence to DLA packaging and marking standards, including MIL-STD-129 and Medical Marking Standard No. 1. Depending on the hazardous classification per FED-STD-313, packaging must follow either TQ requirement IP025 or ASTM D3951, with DLA Master List requirements taking precedence. Additionally, the contract prohibits the intentional addition of mercury or mercury-containing compounds to the supplies. Administrative requirements include the use of the Wide Area WorkFlow (WAWF) system for invoicing and compliance with various FAR and DFARS clauses regarding cybersecurity, domestic material restrictions, and subcontracting for commercial products.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

VARICELLA VIRUS VACCIN

Solicitation # SPE2DP-27-T-0248

This procurement is for the supply of Varicella Virus Vaccine, Live, Lyophilized, under solicitation SPE2DP-27-T-0248. The requirement is for one package consisting of 10 single dose vials of live vaccine and 10 vials of diluent, totaling 20 vials. The product must be drop shipped directly from the manufacturer and stored frozen between -50C and -15C. It must have a total shelf life of 18 months, with at least 15 months remaining upon delivery to the government. Delivery is required within 20 days, FOB Destination, to a facility in Niagara Falls, New York. The contract mandates strict adherence to MIL-STD-2073-1E and Medical Marking Standard No. 1B for packaging and labeling. Inspection and acceptance will occur at the destination per FAR 52.246-2. The solicitation incorporates various DFARS and FAR clauses, including requirements for safeguarding covered defense information, Buy American and Balance of Payments programs, and prohibitions on certain telecommunications equipment. All quotes must be submitted via the DLA Internet Bid Board System, and payment processing is handled through the Wide Area WorkFlow system.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

HYDROGEN PEROXIDE TOPI

Solicitation # SPE2DP-27-T-0247

Solicitation SPE2DP-27-T-0247 is a request for quotations issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of one bottle of Hydrogen Peroxide Topical Solution, USP. The required item is a 3% stabilized topical solution for external use, provided in a 473 milliliter bottle. The delivery is required within 20 days after receipt of the order, with the place of performance and delivery located in Eastover, South Carolina. Inspection and acceptance will occur at the destination in accordance with FAR 52.246-2. The product is regulated by the FDA and classified as a hazardous material, requiring a current Material Safety Data Sheet to be provided to the DLA electronic mailbox and included with each shipment. Packaging must comply with MIL-STD-2073-1E, Special Packaging Instructions MPPWN00001, and Medical Marking Standard No. 1. For shipments via military aircraft, compliance with DLAI 4145.3 is mandatory. Additionally, the contractor must provide a signed certification on DD Form 250 confirming that the package configuration meets 49 CFR and ICAO or IMDG requirements. Administrative requirements include the use of the Wide Area WorkFlow system for electronic invoicing and receiving reports. The contract incorporates several federal regulations, including the Buy American and Balance of Payments Program (DFARS 252.225-7001), safeguarding of covered defense information (DFARS 252.204-7012), and prohibitions on certain telecommunications equipment (DFARS 252.204-7018). Offerors must also validate their representations and certifications within the System for Award Management.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 6 days

AI Contract Overview

The Defense Logistics Agency awarded contract SPE2DP26F9366 to DMS Pharmaceutical Group Inc for the procurement of Naloxone Hydrochloride Injection. This award, valued at 57.48 dollars, was issued on August 31, 2026, as a delivery order under the broader base administrative contract SPE2DX25D9900. The procurement falls under NAICS code 325412 and was managed by the DLA Troop Support Medical Supply Chain. The specific order for the Naloxone Hydrochloride Injection, identified by NSN 6505015334126 and PR 7018130714, requires delivery to Fort Bragg, North Carolina, by August 31, 2026. The overarching base contract SPE2DX25D9900 was originally issued on April 2, 2025, replacing a previous agreement and incorporating standard Federal Acquisition Regulation clauses.

General Info

DLA awarded DMS Pharmaceutical Group 57.48 dollars for Naloxone Hydrochloride Injection delivery.

Agency

Department Of Defense → Defense Logistics Agency

Contract Value

$57.48

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

Not specified

Set-Aside

NONE

Awardee

DMS PHARMACEUTICAL GROUP INC

Award Issued Date

08/31/2026, 12:00:00 AM UTC

Documents

award

High

task-order-award

High

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseAwarded

PostedAug 31

Award Notice

AwardedAug 31

Contract was awarded

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Defense → Defense Logistics Agency

ContactsNo contacts available

OfficeUSA

Organization / AgencyDepartment Of Defense → Defense Logistics Agency

Office AddressUSA

ContactsNo contact information available

Full Description

DLA award SPE2DP26F9366 posted on DIBBS. Awardee: DMS PHARMACEUTICAL GROUP INC (CAGE 1UNB0) Total Contract Price: $57.48 Award Date: 08-31-2026 Delivery order under: SPE2DX25D9900 Line items: - NALOXONE HYDROCHLORIDE INJECTION (NSN/Part 6505015334126, PR 7018130714)